Cargando…
The Value of Phenotypic Precision Medicine in Prostate Cancer
Prostate cancer is the most common cancer among men and the second leading cause of cancer-related death. For patients who develop metastatic disease, tissue-based and circulating-tumor–based molecular and genomic biomarkers have emerged as a means of improving outcomes through the application of pr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907055/ https://www.ncbi.nlm.nih.gov/pubmed/36200788 http://dx.doi.org/10.1093/oncolo/oyac198 |